MGI Tech Partners with Eva Holding Group to Expand Genomic Access in Brazil

October 29, 2025
MGI Tech and Eva Holding Group have formed a strategic partnership to enhance disease monitoring and expand access to genomic sequencing technologies in Brazil, including the first IVD-certified DNBSEQ-T7 sequencer in Latin America.

MGI Tech Co., Ltd. has entered into a strategic partnership with Eva Holding Group to expand access to genomic technologies and improve disease monitoring in Brazil, announced in a press release. The collaboration focuses on enhancing the accuracy of cancer tracking and supporting the development of the country's genetic sector.

The agreement includes the installation of MGI's DNBSEQ-T7 sequencer, the first system with In Vitro Diagnostic (IVD) certification sold in Latin America. It is also the only high-throughput IVDI-certified equipment in Brazil, allowing clinical use of this technology alongside research applications.

The DNBSEQ-T7 system offers high processing capacity and flexibility for whole-genome, exome, and transcriptome sequencing. Its DNBSEQ technology produces high-quality data at reduced cost, supporting more precise variant detection and comprehensive genome assembly.

Eva Holding Group plans to centralize its genomic operations within a new technology park to increase efficiency and scalability. The partnership aims to benefit areas such as oncology, rare disease diagnosis, and neonatal screening through faster and more accurate genomic analysis.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

10/29
ExaCare AI Raises $30M Series A to Expand AI Platform for Skilled Nursing Facilities
10/29
Harbour BioMed Launches Fully Human Generative AI HCAb Model
10/29
MCG Health and Allegheny Health Network to Present on AI in Utilization Management at ACMA 2025
10/29
CareSet Names Sepideh Naseri Chief Data and Analytics Officer
10/29
ID.me and Flexpa Partner to Strengthen Health Data Access and Security

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more

You May Also Like